|
Volumn 41, Issue 1, 2003, Pages 80-82
|
Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification
|
Author keywords
LDH; MYCN amplification; Neuroblastoma; Tumor lysis syndrome
|
Indexed keywords
CATECHOLAMINE;
CREATININE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FUROSEMIDE;
HOMOVANILLIC ACID;
LACTATE DEHYDROGENASE;
POTASSIUM CHLORIDE;
VANILMANDELIC ACID;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
MYCN PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
ARTICLE;
CASE REPORT;
CATECHOLAMINE URINE LEVEL;
CORRELATION ANALYSIS;
DISEASE ASSOCIATION;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE AMPLIFICATION;
HEPATOBLASTOMA;
HUMAN;
HYPERKALEMIA;
HYPERPHOSPHATEMIA;
HYPERURICEMIA;
HYPOCALCEMIA;
INFANT;
KIDNEY FAILURE;
LACTATE DEHYDROGENASE BLOOD LEVEL;
NEUROBLASTOMA;
PRIORITY JOURNAL;
RHABDOMYOSARCOMA;
TUMOR LYSIS SYNDROME;
BLOOD;
FATALITY;
GENETICS;
PATHOLOGY;
RETROPERITONEAL TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FATAL OUTCOME;
FEMALE;
HUMANS;
INFANT;
L-LACTATE DEHYDROGENASE;
NEUROBLASTOMA;
NUCLEAR PROTEINS;
ONCOGENE PROTEINS;
RETROPERITONEAL NEOPLASMS;
TUMOR LYSIS SYNDROME;
|
EID: 0038410073
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.10287 Document Type: Article |
Times cited : (23)
|
References (6)
|